Clinical trial
Radiation Dose Intensity Study in Breast Cancer in Young Women
NCT00212121 · The Netherlands Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00212121 |
|---|---|
| Title | Radiation Dose Intensity Study in Breast Cancer in Young Women |
| Official title | Radiation Dose Intensity Study in Breast Cancer in Young Women: a Randomized Phase III Trial of Additional Dose to the Tumor Bed |
| Lead sponsor | The Netherlands Cancer Institute, Other |
| Collaborators | UNICANCER |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | high dose boost, boost |
| Enrollment | 2,400 |
| Start date | Jul 1, 2004 |
| Primary completion | Dec 1, 2025 |
| Completion | Dec 1, 2025 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 21, 2022 |
| Countries | France, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: